Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfacetamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | DHFR | P00374 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | MMP9 | P14780 | 1/20 | 0.59 |
| ▸ | MMP8 | P22894 | 1/20 | 0.59 |
| ▸ | MMP13 | P45452 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfacetamide SCHEMBL28122264 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL28308067 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL29207414 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL16097762 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL3912378 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL23317 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL2503539 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL28182511 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL15869608 | 0.96 | SMN1; SMN2 (0.93) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 | |
| Sulfacetamide SCHEMBL28631607 | 0.96 | SMN1; SMN2 (0.93) | SMN1; SMN2DHFRTSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19964 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081142-A | Arthropoda pseudolaris X-6 capable of efficiently degrading sulfonamide antibiotics and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260048096-A1 | METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4694929-A1 | METHODS FOR TREATING CORNEAL INJURIES | Lin, Sung-Jan (TW) | 2026-02-18 | — | — | EP | claimed |
| US-20260027255-A1 | Cross-Linked Telechelic Polymer Compositions, Methods of Preparation Thereof, and Methods of Using Same | BETTY YU SKIN TECH ADVISORS LLC (US) | 2026-01-29 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| US-4359544-A | COMPRISING STEARAMIDE AND HIGH DENSITY POLYETHYLENE | SHELL OIL COMPANY (US) | 1982-11-16 | — | — | US | claimed |
| EP-0002349-B1 | PLASTICIZATION OF NEUTRALIZED SULFONATED ELASTOMERIC POLYMER | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1982-09-29 | — | — | EP | claimed |
| US-4188373-A | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes | COOPER LABORATORIES, INC. (US) | 1980-02-12 | — | — | US | claimed |
| US-4186184-A | Selective administration of drug with ocular therapeutic system | ALZA CORPORATION (US) | 1980-01-29 | — | — | US | claimed |
| US-4136173-A | VEHICLES FOR OPHTHALMIC DRUGS | AMERICAN HOME PRODUCTS CORP. (US) | 1979-01-23 | — | — | US | claimed |
| US-4120855-A | Bactericidally active monochlorotriazine dyes | LIVERANT VLADIMIR LEIBOVICH | 1978-10-17 | — | — | US | claimed |
| US-4100271-A | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes | COOPER LABORATORIES, INC. (US) | 1978-07-11 | — | — | US | claimed |
| US-4016251-A | Vaginal drug dispensing device | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-4014335-A | Ocular drug delivery device | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |
| US-3985873-A | OPHTHALMIC ANTIBACTERIAL SOLUTION | BURROUGHS WELLCOME CO. (US) | 1976-10-12 | — | — | US | claimed |